SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

First Page		Document Content
Pharmacology Interferon Betamethasone/calcipotriol Etravirine Peginterferon alfa-2a Prostate cancer Psoriasis Ribavirin Testosterone Medicine Antivirals Health		SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of Add to Reading List Source URL: www.scottishmedicines.org.uk Download Document from Source Website File Size: 268,04 KB Share Document on Facebook

	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	IMPORTANT PLEASE READ PART III: CONSUMER INFORMATION INTRON A® interferon alfa-2b This leaflet is part III of a three-part "Product Monograph" DocID: 1uNBi - View Document
	Evaluation of Interferon-gamma-Producing T Cells DocID: 1uFKZ - View Document
	PRODUCT MONOGRAPH INTRON A® interferon alfa-2b Lyophilized Powder with Diluent: 10 million IU interferon alfa-2b/vial DocID: 1umTG - View Document
	  Data Sheet Recombinant Human Interferon-gamma (rh IFN-) Preclinical Grade - Order No.: µg) DocID: 1u1rK - View Document